Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML)
*Corresponding Author
:
Zeba Singh, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 502 Little Rock, AR 72205, USA, Email: zsingh@uams.edu
Received Date: May 09, 2012 / Accepted Date: Jun 14, 2012 / Published Date: Jun 17, 2012
Keywords: CML; Targeted therapy; Tyrosine kinase inhibitors; Drug resistance; Molecular monitoring
Citation: Singh Z, Medlin S, Usmani SZ (2012) Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML). J Clin Exp Pathol 2:113. Doi: 10.4172/2161-0681.1000113
Copyright: © 2012 Singh Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 24659
- [From(publication date): 6-2012 - Aug 16, 2024]
- Breakdown by view type
- HTML page views: 20086
- PDF downloads: 4573
